Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2019

Nov 12, 2019

SELL
$1.63 - $2.2 $10,376 - $14,005
-6,366 Closed
0 $0
Q2 2019

Aug 09, 2019

SELL
$2.1 - $3.07 $480 - $703
-229 Reduced 3.47%
6,366 $14,000
Q1 2019

May 15, 2019

BUY
$2.7 - $3.65 $17,282 - $23,363
6,401 Added 3299.48%
6,595 $20,000
Q4 2018

Feb 14, 2019

BUY
$2.95 - $3.27 $277 - $307
94 Added 94.0%
194 $1,000
Q3 2018

Nov 13, 2018

BUY
$2.94 - $3.23 $294 - $323
100 New
100 $0

Others Institutions Holding PRPH

About ProPhase Labs, Inc.


  • Ticker PRPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 16,024,400
  • Market Cap $10.4M
  • Description
  • ProPhase Labs, Inc. engages in the research, development, manufacture, distribution, marketing, and sale of over the counter (OTC) consumer healthcare products and dietary supplements in the United States. The company operates in two segments, Diagnostic Services and Consumer Products. It offers a range of OTC dietary supplements, including Lege...
More about PRPH
Track This Portfolio

Track Panagora Asset Management Inc Portfolio

Follow Panagora Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Panagora Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Panagora Asset Management Inc with notifications on news.